nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—PDE5A—Pentoxifylline—systemic scleroderma	0.732	0.964	CbGbCtD
Tadalafil—PDE5A—pulmonary artery—systemic scleroderma	0.0201	0.35	CbGeAlD
Tadalafil—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0154	0.0203	CbGbCtD
Tadalafil—CYP3A4—Prednisone—systemic scleroderma	0.0123	0.0162	CbGbCtD
Tadalafil—PDE5A—artery—systemic scleroderma	0.00744	0.13	CbGeAlD
Tadalafil—PDE5A—endothelium—systemic scleroderma	0.00629	0.11	CbGeAlD
Tadalafil—PDE5A—blood vessel—systemic scleroderma	0.0058	0.101	CbGeAlD
Tadalafil—PDE11A—tendon—systemic scleroderma	0.00537	0.0937	CbGeAlD
Tadalafil—PDE5A—connective tissue—systemic scleroderma	0.00297	0.0519	CbGeAlD
Tadalafil—PDE5A—smooth muscle tissue—systemic scleroderma	0.00272	0.0474	CbGeAlD
Tadalafil—PDE5A—digestive system—systemic scleroderma	0.00215	0.0375	CbGeAlD
Tadalafil—PDE5A—tendon—systemic scleroderma	0.00204	0.0356	CbGeAlD
Tadalafil—PDE5A—lung—systemic scleroderma	0.00179	0.0313	CbGeAlD
Tadalafil—CYP3A4—digestive system—systemic scleroderma	0.000669	0.0117	CbGeAlD
Tadalafil—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000209	0.00114	CcSEcCtD
Tadalafil—Discomfort—Lisinopril—systemic scleroderma	0.000208	0.00114	CcSEcCtD
Tadalafil—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000208	0.00114	CcSEcCtD
Tadalafil—Dyspepsia—Leflunomide—systemic scleroderma	0.000207	0.00113	CcSEcCtD
Tadalafil—Vomiting—Mometasone—systemic scleroderma	0.000207	0.00113	CcSEcCtD
Tadalafil—Dry mouth—Lisinopril—systemic scleroderma	0.000206	0.00112	CcSEcCtD
Tadalafil—Rash—Mometasone—systemic scleroderma	0.000205	0.00112	CcSEcCtD
Tadalafil—Asthenia—Captopril—systemic scleroderma	0.000205	0.00112	CcSEcCtD
Tadalafil—Dermatitis—Mometasone—systemic scleroderma	0.000205	0.00112	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000204	0.00112	CcSEcCtD
Tadalafil—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000204	0.00111	CcSEcCtD
Tadalafil—Headache—Mometasone—systemic scleroderma	0.000204	0.00111	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000203	0.00111	CcSEcCtD
Tadalafil—Insomnia—Mycophenolic acid—systemic scleroderma	0.000203	0.00111	CcSEcCtD
Tadalafil—Fatigue—Leflunomide—systemic scleroderma	0.000203	0.00111	CcSEcCtD
Tadalafil—Oedema—Lisinopril—systemic scleroderma	0.000202	0.0011	CcSEcCtD
Tadalafil—Pruritus—Captopril—systemic scleroderma	0.000202	0.0011	CcSEcCtD
Tadalafil—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000201	0.0011	CcSEcCtD
Tadalafil—Pain—Leflunomide—systemic scleroderma	0.000201	0.0011	CcSEcCtD
Tadalafil—Constipation—Leflunomide—systemic scleroderma	0.000201	0.0011	CcSEcCtD
Tadalafil—Infection—Lisinopril—systemic scleroderma	0.000201	0.0011	CcSEcCtD
Tadalafil—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.0002	0.00109	CcSEcCtD
Tadalafil—Somnolence—Mycophenolic acid—systemic scleroderma	0.000199	0.00109	CcSEcCtD
Tadalafil—Shock—Lisinopril—systemic scleroderma	0.000199	0.00108	CcSEcCtD
Tadalafil—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000198	0.00108	CcSEcCtD
Tadalafil—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000197	0.00108	CcSEcCtD
Tadalafil—Tachycardia—Lisinopril—systemic scleroderma	0.000197	0.00108	CcSEcCtD
Tadalafil—Abdominal pain—Azathioprine—systemic scleroderma	0.000197	0.00107	CcSEcCtD
Tadalafil—Skin disorder—Lisinopril—systemic scleroderma	0.000196	0.00107	CcSEcCtD
Tadalafil—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000195	0.00107	CcSEcCtD
Tadalafil—Diarrhoea—Captopril—systemic scleroderma	0.000195	0.00107	CcSEcCtD
Tadalafil—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000195	0.00106	CcSEcCtD
Tadalafil—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000195	0.00106	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000194	0.00106	CcSEcCtD
Tadalafil—Fatigue—Mycophenolic acid—systemic scleroderma	0.000193	0.00106	CcSEcCtD
Tadalafil—Nausea—Mometasone—systemic scleroderma	0.000193	0.00105	CcSEcCtD
Tadalafil—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000192	0.00105	CcSEcCtD
Tadalafil—Constipation—Mycophenolic acid—systemic scleroderma	0.000192	0.00105	CcSEcCtD
Tadalafil—Pain—Mycophenolic acid—systemic scleroderma	0.000192	0.00105	CcSEcCtD
Tadalafil—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000192	0.00105	CcSEcCtD
Tadalafil—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000191	0.00104	CcSEcCtD
Tadalafil—Cough—Mycophenolate mofetil—systemic scleroderma	0.000189	0.00103	CcSEcCtD
Tadalafil—Hypotension—Lisinopril—systemic scleroderma	0.000189	0.00103	CcSEcCtD
Tadalafil—Dizziness—Captopril—systemic scleroderma	0.000189	0.00103	CcSEcCtD
Tadalafil—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000188	0.00103	CcSEcCtD
Tadalafil—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000188	0.00103	CcSEcCtD
Tadalafil—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000187	0.00102	CcSEcCtD
Tadalafil—Urticaria—Leflunomide—systemic scleroderma	0.000187	0.00102	CcSEcCtD
Tadalafil—Abdominal pain—Leflunomide—systemic scleroderma	0.000186	0.00101	CcSEcCtD
Tadalafil—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000186	0.00101	CcSEcCtD
Tadalafil—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000185	0.00101	CcSEcCtD
Tadalafil—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000185	0.00101	CcSEcCtD
Tadalafil—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000185	0.00101	CcSEcCtD
Tadalafil—Myocardial infarction—Prednisone—systemic scleroderma	0.000184	0.00101	CcSEcCtD
Tadalafil—Breast disorder—Methotrexate—systemic scleroderma	0.000184	0.00101	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000184	0.001	CcSEcCtD
Tadalafil—Hypersensitivity—Azathioprine—systemic scleroderma	0.000183	0.001	CcSEcCtD
Tadalafil—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000183	0.001	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000183	0.001	CcSEcCtD
Tadalafil—Insomnia—Lisinopril—systemic scleroderma	0.000183	0.000997	CcSEcCtD
Tadalafil—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000182	0.000996	CcSEcCtD
Tadalafil—Paraesthesia—Lisinopril—systemic scleroderma	0.000181	0.00099	CcSEcCtD
Tadalafil—Vomiting—Captopril—systemic scleroderma	0.000181	0.00099	CcSEcCtD
Tadalafil—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000181	0.000986	CcSEcCtD
Tadalafil—Dyspnoea—Lisinopril—systemic scleroderma	0.00018	0.000983	CcSEcCtD
Tadalafil—Rash—Captopril—systemic scleroderma	0.00018	0.000982	CcSEcCtD
Tadalafil—Dermatitis—Captopril—systemic scleroderma	0.00018	0.000981	CcSEcCtD
Tadalafil—Somnolence—Lisinopril—systemic scleroderma	0.00018	0.00098	CcSEcCtD
Tadalafil—Headache—Captopril—systemic scleroderma	0.000179	0.000975	CcSEcCtD
Tadalafil—Dyspepsia—Lisinopril—systemic scleroderma	0.000178	0.000971	CcSEcCtD
Tadalafil—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000177	0.000968	CcSEcCtD
Tadalafil—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000966	CcSEcCtD
Tadalafil—Infection—Mycophenolate mofetil—systemic scleroderma	0.000176	0.00096	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000174	0.000952	CcSEcCtD
Tadalafil—Fatigue—Lisinopril—systemic scleroderma	0.000174	0.000951	CcSEcCtD
Tadalafil—Shock—Mycophenolate mofetil—systemic scleroderma	0.000174	0.00095	CcSEcCtD
Tadalafil—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000947	CcSEcCtD
Tadalafil—Hypersensitivity—Leflunomide—systemic scleroderma	0.000173	0.000945	CcSEcCtD
Tadalafil—Pain—Lisinopril—systemic scleroderma	0.000173	0.000943	CcSEcCtD
Tadalafil—Constipation—Lisinopril—systemic scleroderma	0.000173	0.000943	CcSEcCtD
Tadalafil—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000943	CcSEcCtD
Tadalafil—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000938	CcSEcCtD
Tadalafil—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000934	CcSEcCtD
Tadalafil—Diarrhoea—Azathioprine—systemic scleroderma	0.00017	0.00093	CcSEcCtD
Tadalafil—Haemoglobin—Prednisone—systemic scleroderma	0.00017	0.000926	CcSEcCtD
Tadalafil—Nausea—Captopril—systemic scleroderma	0.000169	0.000925	CcSEcCtD
Tadalafil—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000169	0.000923	CcSEcCtD
Tadalafil—Haemorrhage—Prednisone—systemic scleroderma	0.000169	0.000922	CcSEcCtD
Tadalafil—Asthenia—Leflunomide—systemic scleroderma	0.000169	0.000921	CcSEcCtD
Tadalafil—Pruritus—Leflunomide—systemic scleroderma	0.000166	0.000908	CcSEcCtD
Tadalafil—Connective tissue disorder—Prednisone—systemic scleroderma	0.000166	0.000906	CcSEcCtD
Tadalafil—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000165	0.000903	CcSEcCtD
Tadalafil—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000165	0.000902	CcSEcCtD
Tadalafil—Dizziness—Azathioprine—systemic scleroderma	0.000165	0.000899	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000164	0.000894	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000161	0.00088	CcSEcCtD
Tadalafil—Asthenia—Mycophenolic acid—systemic scleroderma	0.000161	0.000878	CcSEcCtD
Tadalafil—Diarrhoea—Leflunomide—systemic scleroderma	0.000161	0.000878	CcSEcCtD
Tadalafil—Urticaria—Lisinopril—systemic scleroderma	0.000161	0.000876	CcSEcCtD
Tadalafil—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000874	CcSEcCtD
Tadalafil—Abdominal pain—Lisinopril—systemic scleroderma	0.00016	0.000872	CcSEcCtD
Tadalafil—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000867	CcSEcCtD
Tadalafil—Pruritus—Mycophenolic acid—systemic scleroderma	0.000159	0.000866	CcSEcCtD
Tadalafil—Vomiting—Azathioprine—systemic scleroderma	0.000158	0.000864	CcSEcCtD
Tadalafil—Eye disorder—Prednisone—systemic scleroderma	0.000158	0.000861	CcSEcCtD
Tadalafil—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000861	CcSEcCtD
Tadalafil—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000157	0.000859	CcSEcCtD
Tadalafil—Infestation NOS—Methotrexate—systemic scleroderma	0.000157	0.000858	CcSEcCtD
Tadalafil—Infestation—Methotrexate—systemic scleroderma	0.000157	0.000858	CcSEcCtD
Tadalafil—Rash—Azathioprine—systemic scleroderma	0.000157	0.000857	CcSEcCtD
Tadalafil—Dermatitis—Azathioprine—systemic scleroderma	0.000157	0.000856	CcSEcCtD
Tadalafil—Flushing—Prednisone—systemic scleroderma	0.000157	0.000855	CcSEcCtD
Tadalafil—Headache—Azathioprine—systemic scleroderma	0.000156	0.000851	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000156	0.000851	CcSEcCtD
Tadalafil—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000156	0.00085	CcSEcCtD
Tadalafil—Dizziness—Leflunomide—systemic scleroderma	0.000156	0.000849	CcSEcCtD
Tadalafil—Renal failure—Methotrexate—systemic scleroderma	0.000155	0.000843	CcSEcCtD
Tadalafil—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000154	0.000838	CcSEcCtD
Tadalafil—Angiopathy—Prednisone—systemic scleroderma	0.000153	0.000836	CcSEcCtD
Tadalafil—Conjunctivitis—Methotrexate—systemic scleroderma	0.000153	0.000834	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000834	CcSEcCtD
Tadalafil—Immune system disorder—Prednisone—systemic scleroderma	0.000153	0.000833	CcSEcCtD
Tadalafil—Pain—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000826	CcSEcCtD
Tadalafil—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000826	CcSEcCtD
Tadalafil—Sweating—Methotrexate—systemic scleroderma	0.000151	0.000823	CcSEcCtD
Tadalafil—Haematuria—Methotrexate—systemic scleroderma	0.00015	0.000818	CcSEcCtD
Tadalafil—Vomiting—Leflunomide—systemic scleroderma	0.00015	0.000816	CcSEcCtD
Tadalafil—Hypersensitivity—Lisinopril—systemic scleroderma	0.000149	0.000812	CcSEcCtD
Tadalafil—Dizziness—Mycophenolic acid—systemic scleroderma	0.000148	0.000809	CcSEcCtD
Tadalafil—Epistaxis—Methotrexate—systemic scleroderma	0.000148	0.000809	CcSEcCtD
Tadalafil—Rash—Leflunomide—systemic scleroderma	0.000148	0.000809	CcSEcCtD
Tadalafil—Dermatitis—Leflunomide—systemic scleroderma	0.000148	0.000808	CcSEcCtD
Tadalafil—Mental disorder—Prednisone—systemic scleroderma	0.000148	0.000808	CcSEcCtD
Tadalafil—Nausea—Azathioprine—systemic scleroderma	0.000148	0.000807	CcSEcCtD
Tadalafil—Headache—Leflunomide—systemic scleroderma	0.000147	0.000804	CcSEcCtD
Tadalafil—Asthenia—Lisinopril—systemic scleroderma	0.000145	0.000791	CcSEcCtD
Tadalafil—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000145	0.00079	CcSEcCtD
Tadalafil—Pruritus—Lisinopril—systemic scleroderma	0.000143	0.00078	CcSEcCtD
Tadalafil—Vomiting—Mycophenolic acid—systemic scleroderma	0.000143	0.000778	CcSEcCtD
Tadalafil—Haemoglobin—Methotrexate—systemic scleroderma	0.000142	0.000774	CcSEcCtD
Tadalafil—Rash—Mycophenolic acid—systemic scleroderma	0.000141	0.000772	CcSEcCtD
Tadalafil—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000141	0.000771	CcSEcCtD
Tadalafil—Haemorrhage—Methotrexate—systemic scleroderma	0.000141	0.00077	CcSEcCtD
Tadalafil—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000767	CcSEcCtD
Tadalafil—Headache—Mycophenolic acid—systemic scleroderma	0.000141	0.000767	CcSEcCtD
Tadalafil—Pharyngitis—Methotrexate—systemic scleroderma	0.00014	0.000765	CcSEcCtD
Tadalafil—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00014	0.000764	CcSEcCtD
Tadalafil—Nausea—Leflunomide—systemic scleroderma	0.00014	0.000762	CcSEcCtD
Tadalafil—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000139	0.000761	CcSEcCtD
Tadalafil—Vision blurred—Prednisone—systemic scleroderma	0.000139	0.000756	CcSEcCtD
Tadalafil—Urethral disorder—Methotrexate—systemic scleroderma	0.000138	0.000755	CcSEcCtD
Tadalafil—Diarrhoea—Lisinopril—systemic scleroderma	0.000138	0.000754	CcSEcCtD
Tadalafil—Angioedema—Prednisone—systemic scleroderma	0.000134	0.000733	CcSEcCtD
Tadalafil—Dizziness—Lisinopril—systemic scleroderma	0.000134	0.000729	CcSEcCtD
Tadalafil—Erythema multiforme—Methotrexate—systemic scleroderma	0.000133	0.000728	CcSEcCtD
Tadalafil—Nausea—Mycophenolic acid—systemic scleroderma	0.000133	0.000727	CcSEcCtD
Tadalafil—Vertigo—Prednisone—systemic scleroderma	0.000132	0.000721	CcSEcCtD
Tadalafil—Eye disorder—Methotrexate—systemic scleroderma	0.000132	0.00072	CcSEcCtD
Tadalafil—Syncope—Prednisone—systemic scleroderma	0.000132	0.00072	CcSEcCtD
Tadalafil—Tinnitus—Methotrexate—systemic scleroderma	0.000132	0.000718	CcSEcCtD
Tadalafil—Cardiac disorder—Methotrexate—systemic scleroderma	0.000131	0.000715	CcSEcCtD
Tadalafil—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000712	CcSEcCtD
Tadalafil—Loss of consciousness—Prednisone—systemic scleroderma	0.000129	0.000705	CcSEcCtD
Tadalafil—Vomiting—Lisinopril—systemic scleroderma	0.000128	0.000701	CcSEcCtD
Tadalafil—Angiopathy—Methotrexate—systemic scleroderma	0.000128	0.000699	CcSEcCtD
Tadalafil—Immune system disorder—Methotrexate—systemic scleroderma	0.000128	0.000696	CcSEcCtD
Tadalafil—Rash—Lisinopril—systemic scleroderma	0.000127	0.000695	CcSEcCtD
Tadalafil—Convulsion—Prednisone—systemic scleroderma	0.000127	0.000695	CcSEcCtD
Tadalafil—Dermatitis—Lisinopril—systemic scleroderma	0.000127	0.000695	CcSEcCtD
Tadalafil—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000127	0.000694	CcSEcCtD
Tadalafil—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000127	0.000693	CcSEcCtD
Tadalafil—Hypertension—Prednisone—systemic scleroderma	0.000127	0.000693	CcSEcCtD
Tadalafil—Headache—Lisinopril—systemic scleroderma	0.000127	0.000691	CcSEcCtD
Tadalafil—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000125	0.000683	CcSEcCtD
Tadalafil—Myalgia—Prednisone—systemic scleroderma	0.000125	0.000683	CcSEcCtD
Tadalafil—Arthralgia—Prednisone—systemic scleroderma	0.000125	0.000683	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000124	0.000678	CcSEcCtD
Tadalafil—Discomfort—Prednisone—systemic scleroderma	0.000124	0.000675	CcSEcCtD
Tadalafil—Mental disorder—Methotrexate—systemic scleroderma	0.000124	0.000675	CcSEcCtD
Tadalafil—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000661	CcSEcCtD
Tadalafil—Nausea—Lisinopril—systemic scleroderma	0.00012	0.000655	CcSEcCtD
Tadalafil—Oedema—Prednisone—systemic scleroderma	0.00012	0.000655	CcSEcCtD
Tadalafil—Infection—Prednisone—systemic scleroderma	0.000119	0.000651	CcSEcCtD
Tadalafil—Back pain—Methotrexate—systemic scleroderma	0.000119	0.000649	CcSEcCtD
Tadalafil—Shock—Prednisone—systemic scleroderma	0.000118	0.000644	CcSEcCtD
Tadalafil—Nervous system disorder—Prednisone—systemic scleroderma	0.000118	0.000642	CcSEcCtD
Tadalafil—Tachycardia—Prednisone—systemic scleroderma	0.000117	0.000639	CcSEcCtD
Tadalafil—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000639	CcSEcCtD
Tadalafil—Skin disorder—Prednisone—systemic scleroderma	0.000117	0.000636	CcSEcCtD
Tadalafil—Hyperhidrosis—Prednisone—systemic scleroderma	0.000116	0.000633	CcSEcCtD
Tadalafil—Vision blurred—Methotrexate—systemic scleroderma	0.000116	0.000632	CcSEcCtD
Tadalafil—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000113	0.000614	CcSEcCtD
Tadalafil—Rash—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000609	CcSEcCtD
Tadalafil—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000609	CcSEcCtD
Tadalafil—Headache—Mycophenolate mofetil—systemic scleroderma	0.000111	0.000605	CcSEcCtD
Tadalafil—Vertigo—Methotrexate—systemic scleroderma	0.00011	0.000602	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000109	0.000597	CcSEcCtD
Tadalafil—Insomnia—Prednisone—systemic scleroderma	0.000109	0.000592	CcSEcCtD
Tadalafil—Paraesthesia—Prednisone—systemic scleroderma	0.000108	0.000588	CcSEcCtD
Tadalafil—Cough—Methotrexate—systemic scleroderma	0.000107	0.000585	CcSEcCtD
Tadalafil—Convulsion—Methotrexate—systemic scleroderma	0.000106	0.000581	CcSEcCtD
Tadalafil—Dyspepsia—Prednisone—systemic scleroderma	0.000106	0.000576	CcSEcCtD
Tadalafil—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000105	0.000574	CcSEcCtD
Tadalafil—Myalgia—Methotrexate—systemic scleroderma	0.000105	0.000571	CcSEcCtD
Tadalafil—Chest pain—Methotrexate—systemic scleroderma	0.000105	0.000571	CcSEcCtD
Tadalafil—Arthralgia—Methotrexate—systemic scleroderma	0.000105	0.000571	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000104	0.000567	CcSEcCtD
Tadalafil—Fatigue—Prednisone—systemic scleroderma	0.000103	0.000565	CcSEcCtD
Tadalafil—Discomfort—Methotrexate—systemic scleroderma	0.000103	0.000564	CcSEcCtD
Tadalafil—Constipation—Prednisone—systemic scleroderma	0.000103	0.00056	CcSEcCtD
Tadalafil—Infection—Methotrexate—systemic scleroderma	9.96e-05	0.000544	CcSEcCtD
Tadalafil—Nervous system disorder—Methotrexate—systemic scleroderma	9.84e-05	0.000537	CcSEcCtD
Tadalafil—Gastrointestinal pain—Prednisone—systemic scleroderma	9.81e-05	0.000535	CcSEcCtD
Tadalafil—Skin disorder—Methotrexate—systemic scleroderma	9.74e-05	0.000532	CcSEcCtD
Tadalafil—Hyperhidrosis—Methotrexate—systemic scleroderma	9.7e-05	0.000529	CcSEcCtD
Tadalafil—Urticaria—Prednisone—systemic scleroderma	9.53e-05	0.00052	CcSEcCtD
Tadalafil—Abdominal pain—Prednisone—systemic scleroderma	9.49e-05	0.000518	CcSEcCtD
Tadalafil—Hypotension—Methotrexate—systemic scleroderma	9.37e-05	0.000511	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	9.14e-05	0.000499	CcSEcCtD
Tadalafil—Insomnia—Methotrexate—systemic scleroderma	9.07e-05	0.000495	CcSEcCtD
Tadalafil—Paraesthesia—Methotrexate—systemic scleroderma	9.01e-05	0.000491	CcSEcCtD
Tadalafil—Dyspnoea—Methotrexate—systemic scleroderma	8.94e-05	0.000488	CcSEcCtD
Tadalafil—Somnolence—Methotrexate—systemic scleroderma	8.92e-05	0.000487	CcSEcCtD
Tadalafil—Hypersensitivity—Prednisone—systemic scleroderma	8.84e-05	0.000482	CcSEcCtD
Tadalafil—Dyspepsia—Methotrexate—systemic scleroderma	8.83e-05	0.000482	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Methotrexate—systemic scleroderma	8.66e-05	0.000472	CcSEcCtD
Tadalafil—Fatigue—Methotrexate—systemic scleroderma	8.65e-05	0.000472	CcSEcCtD
Tadalafil—Asthenia—Prednisone—systemic scleroderma	8.61e-05	0.00047	CcSEcCtD
Tadalafil—Pain—Methotrexate—systemic scleroderma	8.58e-05	0.000468	CcSEcCtD
Tadalafil—Pruritus—Prednisone—systemic scleroderma	8.49e-05	0.000463	CcSEcCtD
Tadalafil—Diarrhoea—Prednisone—systemic scleroderma	8.21e-05	0.000448	CcSEcCtD
Tadalafil—Gastrointestinal pain—Methotrexate—systemic scleroderma	8.2e-05	0.000448	CcSEcCtD
Tadalafil—Urticaria—Methotrexate—systemic scleroderma	7.97e-05	0.000435	CcSEcCtD
Tadalafil—Dizziness—Prednisone—systemic scleroderma	7.94e-05	0.000433	CcSEcCtD
Tadalafil—Abdominal pain—Methotrexate—systemic scleroderma	7.93e-05	0.000433	CcSEcCtD
Tadalafil—Vomiting—Prednisone—systemic scleroderma	7.63e-05	0.000416	CcSEcCtD
Tadalafil—Rash—Prednisone—systemic scleroderma	7.57e-05	0.000413	CcSEcCtD
Tadalafil—Dermatitis—Prednisone—systemic scleroderma	7.56e-05	0.000413	CcSEcCtD
Tadalafil—Headache—Prednisone—systemic scleroderma	7.52e-05	0.00041	CcSEcCtD
Tadalafil—Hypersensitivity—Methotrexate—systemic scleroderma	7.39e-05	0.000403	CcSEcCtD
Tadalafil—Asthenia—Methotrexate—systemic scleroderma	7.2e-05	0.000393	CcSEcCtD
Tadalafil—Nausea—Prednisone—systemic scleroderma	7.13e-05	0.000389	CcSEcCtD
Tadalafil—Pruritus—Methotrexate—systemic scleroderma	7.1e-05	0.000387	CcSEcCtD
Tadalafil—Diarrhoea—Methotrexate—systemic scleroderma	6.86e-05	0.000374	CcSEcCtD
Tadalafil—Dizziness—Methotrexate—systemic scleroderma	6.63e-05	0.000362	CcSEcCtD
Tadalafil—Vomiting—Methotrexate—systemic scleroderma	6.38e-05	0.000348	CcSEcCtD
Tadalafil—Rash—Methotrexate—systemic scleroderma	6.32e-05	0.000345	CcSEcCtD
Tadalafil—Dermatitis—Methotrexate—systemic scleroderma	6.32e-05	0.000345	CcSEcCtD
Tadalafil—Headache—Methotrexate—systemic scleroderma	6.28e-05	0.000343	CcSEcCtD
Tadalafil—Nausea—Methotrexate—systemic scleroderma	5.96e-05	0.000325	CcSEcCtD
